UroGen Pharma (URGN) Interest & Investment Income (2017 - 2026)
UroGen Pharma's Interest & Investment Income was $599,000 in Q2 2026, down 53.9% from $1.3 million a year earlier and down 1.5% from the prior quarter.
Powered by 
Analysis
UroGen Pharma (URGN) Interest & Investment Income (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, UroGen Pharma's Interest & Investment Income was $3.09 million through Jun 30, 2026, down 64.7% year-over-year; for FY2025, it came in at $5.3 million, down 38.9% from FY2024.
- Interest & Investment Income shows a five-year compound annual growth rate of 21.7% (FY2020 to FY2025).
- In earlier years, Interest & Investment Income was $8.67 million in FY2024 (+149.3%), $3.48 million in FY2023 (+244.5%), $1.01 million in FY2022 (+176.7%) and $365,000 in FY2021 (-81.6%).
- The Q2 2026 figure marks the lowest quarterly Interest & Investment Income since Q2 2023.
- Compared with a year earlier, Interest & Investment Income has declined for five straight quarters, with growth averaging 2.2% over the last eight quarters.
- The best year-over-year quarter for Interest & Investment Income over five years was Q3 2022 (growth of 738.6%); the worst was Q4 2021 (a decline of 92.5%).
- Per Business Quant data, URGN's Interest & Investment Income in the three quarters before Q2 2026 was $608,000 (Q1 2026), $903,000 (Q4 2025) and $979,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | UroGen Pharma | 2.02 Bn | 1.53 Bn | 65.88 Mn | 599,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 599,000.00 |
| Mar 31, 2026 | 608,000.00 |
| Dec 31, 2025 | 903,000.00 |
| Sep 30, 2025 | 979,000.00 |
| Jun 30, 2025 | 1.30 Mn |
| Mar 31, 2025 | 2.11 Mn |
| Dec 31, 2024 | 2.75 Mn |
| Sep 30, 2024 | 2.60 Mn |
| Jun 30, 2024 | 1.71 Mn |
| Mar 31, 2024 | 1.62 Mn |
| Dec 31, 2023 | 1.54 Mn |
| Sep 30, 2023 | 906,000.00 |
| Jun 30, 2023 | 405,000.00 |
| Mar 31, 2023 | 630,000.00 |
| Dec 31, 2022 | 406,000.00 |
| Sep 30, 2022 | 478,000.00 |
| Jun 30, 2022 | 128,000.00 |
| Mar 31, 2022 | -2,000.00 |
| Dec 31, 2021 | 20,000.00 |
| Sep 30, 2021 | 57,000.00 |
API Access
UroGen Pharma Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();